BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8620402)

  • 1. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.
    Jatzko GR; Lisborg PH; Denk H; Klimpfinger M; Stettner HM
    Cancer; 1995 Oct; 76(8):1302-12. PubMed ID: 8620402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stomach carcinoma. Optimizing therapy by extended lymph node dissection].
    Jatzko GR; Lisborg PH; Denk H; Stettner HM
    Zentralbl Chir; 1999; 124(5):376-80. PubMed ID: 10420521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term outcome of stomach carcinoma achieved in an Austrian standard hospital with an oncologic focus].
    Jagoditsch M; Pertl A; Jatzko GR; Denk H; Stettner HM
    Chirurg; 2001 Jul; 72(7):822-31. PubMed ID: 11490761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical surgery (R2 resection) for gastric cancer. A multivariate analysis.
    Lisborg P; Jatzko G; Horn M; Neumann HJ; Müller M; Stettner H; Denk H
    Scand J Gastroenterol; 1994 Nov; 29(11):1024-8. PubMed ID: 7871368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?
    Tokunaga M; Ohyama S; Hiki N; Fukunaga T; Aikou S; Yamaguchi T
    Ann Surg Oncol; 2010 Aug; 17(8):2031-6. PubMed ID: 20182811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenectomy in patients with gastric cancer. A critical review.
    Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
    Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended (D2) lymphadenectomy in gastric cancer: a five year experience.
    Pugliese R; Maggioni D; Berardi V; Scandroglio I; Pisani D; Mariani A; Di Lernia S; Valli C; Cocotta E
    Int Surg; 2000; 85(3):209-15. PubMed ID: 11324997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of para-aortic nodal dissection for advanced gastric cancer.
    Morita S; Fukagawa T; Fujiwara H; Katai H
    Eur J Surg Oncol; 2016 Sep; 42(9):1448-54. PubMed ID: 26876636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.
    Deng J; Liang H; Sun D; Zhang R; Zhan H; Wang X
    Can J Gastroenterol; 2008 Oct; 22(10):835-9. PubMed ID: 18925308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study].
    Roviello F; Marrelli D; Morgagni P; De Manzoni G; Di Leo A; Vindigni C; Nastri G; Saragoni L; Tomezzoli A; Kurihara H; De Stefano A
    Chir Ital; 2003; 55(4):491-8. PubMed ID: 12938593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.
    Siewert JR; Böttcher K; Stein HJ; Roder JD
    Ann Surg; 1998 Oct; 228(4):449-61. PubMed ID: 9790335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in gastric carcinoma after R0 resection with DII lymph node dissection. Tunisian experience.
    Ayadi S; Daghfous A; Makni A; Fteriche F; Maghrebi H; Rebai W; Bedioui H; Chebbi F; Ksantini R; Ammous A; Jouini M; Kacem M; Ben Safta Z
    Tunis Med; 2012 Nov; 90(11):812-5. PubMed ID: 23197061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.